Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raymond R Mattingly

Showing results (1-10 of 59) with videos related to

Pageof 6
Sort By:
ISRN Oncology|December 3, 2013
Activated Ras as a Therapeutic Target: Constraints on Directly Targeting Ras Isoforms and Wild-Type versus Mutated ProteinsRaymond R Mattingly
Methods in Molecular Biology (Clifton, N.J.)|March 6, 2003
Mitogen-activated protein kinase signaling in drug-resistant neuroblastoma cellsRaymond R Mattingly
Neoplasia (New York, N.Y.)|December 3, 2008
Restoration of E-cadherin cell-cell junctions requires both expression of E-cadherin and suppression of ERK MAP kinase activation in Ras-transformed breast epithelial cellsQuanwen Li, Raymond R Mattingly
Molecular Biology of the Cell|February 17, 2006
The Ras-GRF1 exchange factor coordinates activation of H-Ras and Rac1 to control neuronal morphologyHuibin Yang, Raymond R Mattingly
Cancers|December 11, 2025
Challenges and Progress for Treatment of Malignant Peripheral Nerve Sheath Tumors in the Context of Recent Successes for Sarcoma TherapyJohn F Callaghan, Raymond R Mattingly
Cellular Signalling|October 25, 2003
Cell surface receptors activate p21-activated kinase 1 via multiple Ras and PI3-kinase-dependent pathwaysRaymond E Menard, Raymond R Mattingly
FEBS Letters|January 7, 2004
Gbetagamma subunits stimulate p21-activated kinase 1 (PAK1) through activation of PI3-kinase and Akt but act independently of Rac1/Cdc42Raymond E Menard, Raymond R Mattingly
The Journal of Pharmacology and Experimental Therapeutics|December 3, 2009
Three-dimensional overlay culture models of human breast cancer reveal a critical sensitivity to mitogen-activated protein kinase kinase inhibitorsQuanwen Li, Albert B Chow, Raymond R Mattingly
Plos One|August 7, 2024
Electrical stimulation of Schwann cells on electrospun hyaluronic acid carbon nanotube fibersJudy Senanayake, Raymond R Mattingly, Harini G Sundararaghavan
Molecular and Cellular Pharmacology|April 27, 2010
Working together: Farnesyl transferase inhibitors and statins block protein prenylationJonathan W Wojtkowiak, Richard A Gibbs, Raymond R Mattingly
Pageof 6

Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
ISRN Oncology|December 3, 2013
Activated Ras as a Therapeutic Target: Constraints on Directly Targeting Ras Isoforms and Wild-Type versus Mutated ProteinsRaymond R Mattingly
Methods in Molecular Biology (Clifton, N.J.)|March 6, 2003
Mitogen-activated protein kinase signaling in drug-resistant neuroblastoma cellsRaymond R Mattingly
Neoplasia (New York, N.Y.)|December 3, 2008
Restoration of E-cadherin cell-cell junctions requires both expression of E-cadherin and suppression of ERK MAP kinase activation in Ras-transformed breast epithelial cellsQuanwen Li, Raymond R Mattingly
Molecular Biology of the Cell|February 17, 2006
The Ras-GRF1 exchange factor coordinates activation of H-Ras and Rac1 to control neuronal morphologyHuibin Yang, Raymond R Mattingly
Cancers|December 11, 2025
Challenges and Progress for Treatment of Malignant Peripheral Nerve Sheath Tumors in the Context of Recent Successes for Sarcoma TherapyJohn F Callaghan, Raymond R Mattingly
Cellular Signalling|October 25, 2003
Cell surface receptors activate p21-activated kinase 1 via multiple Ras and PI3-kinase-dependent pathwaysRaymond E Menard, Raymond R Mattingly
FEBS Letters|January 7, 2004
Gbetagamma subunits stimulate p21-activated kinase 1 (PAK1) through activation of PI3-kinase and Akt but act independently of Rac1/Cdc42Raymond E Menard, Raymond R Mattingly
The Journal of Pharmacology and Experimental Therapeutics|December 3, 2009
Three-dimensional overlay culture models of human breast cancer reveal a critical sensitivity to mitogen-activated protein kinase kinase inhibitorsQuanwen Li, Albert B Chow, Raymond R Mattingly
Plos One|August 7, 2024
Electrical stimulation of Schwann cells on electrospun hyaluronic acid carbon nanotube fibersJudy Senanayake, Raymond R Mattingly, Harini G Sundararaghavan
Molecular and Cellular Pharmacology|April 27, 2010
Working together: Farnesyl transferase inhibitors and statins block protein prenylationJonathan W Wojtkowiak, Richard A Gibbs, Raymond R Mattingly
Pageof 6